Loading...
Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease
Repeated failures of “Aβ-lowering” therapies call for new targets and therapeutic approaches for Alzheimer's disease (AD). We propose to treat AD by halting neuronal death and repairing synapses using a BDNF-based therapy. To overcome the poor druggability of BDNF, we have developed an agonisti...
Na minha lista:
| Udgivet i: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7295064/ https://ncbi.nlm.nih.gov/pubmed/32550908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.44165 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|